Monogram Biosciences, Inc.·4

Feb 27, 3:54 PM ET

SIEBEL KENNETH F 4

4 · Monogram Biosciences, Inc. · Filed Feb 27, 2009

Insider Transaction Report

Form 4
Period: 2009-02-02
Transactions
  • Sale

    Common Stock

    2009-02-17$3.53/sh5,466$19,2951,443,804 total(indirect: By LLC)
  • Sale

    Common Stock

    2009-02-09$4.24/sh1,200$5,0881,449,270 total(indirect: By LLC)
  • Sale

    Common Stock

    2009-02-02$2.99/sh3,334$9,9691,450,470 total(indirect: By LLC)
Holdings
  • Common Stock

    1,635,333
Footnotes (1)
  • [F1]Represents shares of the issuer's common stock beneficially owned by Private Wealth Partners LLC, a California limited liability company and a registered investment adviser ("IA"), which are beneficially owned indirectly by Mr. Siebel. Mr. Siebel controls IA by virtue of Mr. Siebel's position as a majority managing member of IA. IA acts as investment advisor to PWP Partnership Fund, LLC and manages discretionary client accounts that include shares of the issuer's common stock.

Documents

1 file
  • 4
    v141548_ex.xmlPrimary